中国现代医生
中國現代醫生
중국현대의생
CHINA MODERN DOCTOR
2014年
26期
87-89,92
,共4页
黄文%叶白茹%李占园%金茹%周志宏
黃文%葉白茹%李佔園%金茹%週誌宏
황문%협백여%리점완%금여%주지굉
血液透析%感染%季节%病原学
血液透析%感染%季節%病原學
혈액투석%감염%계절%병원학
Hemodialysis%Infection%Season%Pathogen
目的:初步了解我院血液透析患者并发感染的流行病学情况。方法选择2010年4月1日~2013年8月1日因为感染而住院的60人次、55例患者,对其临床、生化资料进行统计分析。结果55例患者发生60人次感染,感染率为28.57%。年龄、糖尿病、血白蛋白水平是可能的易感因素。革兰阳性菌感染占51.67%,革兰阴性菌感染占36.67%,导管相关性感染占43.33%;肺部感染为48.33%。药敏结果显示,青霉素、头孢他啶、左氧氟沙星、链霉素对革兰阳性菌均有较高的耐药率;四季之间感染分布无统计学意义。结论血透患者感染率较高,多为肺部感染及导管相关性感染,其感染耐药率很高。
目的:初步瞭解我院血液透析患者併髮感染的流行病學情況。方法選擇2010年4月1日~2013年8月1日因為感染而住院的60人次、55例患者,對其臨床、生化資料進行統計分析。結果55例患者髮生60人次感染,感染率為28.57%。年齡、糖尿病、血白蛋白水平是可能的易感因素。革蘭暘性菌感染佔51.67%,革蘭陰性菌感染佔36.67%,導管相關性感染佔43.33%;肺部感染為48.33%。藥敏結果顯示,青黴素、頭孢他啶、左氧氟沙星、鏈黴素對革蘭暘性菌均有較高的耐藥率;四季之間感染分佈無統計學意義。結論血透患者感染率較高,多為肺部感染及導管相關性感染,其感染耐藥率很高。
목적:초보료해아원혈액투석환자병발감염적류행병학정황。방법선택2010년4월1일~2013년8월1일인위감염이주원적60인차、55례환자,대기림상、생화자료진행통계분석。결과55례환자발생60인차감염,감염솔위28.57%。년령、당뇨병、혈백단백수평시가능적역감인소。혁란양성균감염점51.67%,혁란음성균감염점36.67%,도관상관성감염점43.33%;폐부감염위48.33%。약민결과현시,청매소、두포타정、좌양불사성、련매소대혁란양성균균유교고적내약솔;사계지간감염분포무통계학의의。결론혈투환자감염솔교고,다위폐부감염급도관상관성감염,기감염내약솔흔고。
Objective To investigate the epidemiological features of infection among hemodialysis patients. Methods A total of 55 hemodialysis hospitalized patients diagnosed with infection were enrolled in this retrospective study from April 2010 to Augest 2013. Clinical date from 55 patients, were collected and analyzed with SPSS software. Results The 55 hemodialysis patients in 60 cases time got infected during the study, and the infection rate was 28.57%. Age, diabetes, hemoglobin were risk factors for infection. Pathogenic analysis showed 51.67% of infection was caused by gram-positive bacteria, 36.67% of infection was caused by gram-negative bacteria. The infection sites included vascu-lar access infection (43.33%) and lung infecton (48.33%). Drug sensitive tests showed that drug resistant rate of gram-positive bacteria to penicillin, ceftazidime, levofloxacin, streptomycin was high. There was no significance in the sea-sonal distribution of infection. Conclusion Infection rate is high in hemodialysis patients. Vascular access infection and lung infection are dominant infection sites.Drug resistance rate is high in infectious hemodialysis patients.